Search results
Results from the WOW.Com Content Network
Oncology Information System (OIS) is a software solution that manages departmental, administrative and clinical activities in cancer care. It aggregates information into a complete oncology -specific electronic health record to support medical information management.
SWOG (formerly the Southwest Oncology Group) is a National Cancer Institute (NCI)-supported organization that conducts clinical trials in adult cancers.It is one of five "network groups" that make up the U.S. National Clinical Trials Network.
US Oncology Research, The US Oncology Network and McKesson Specialty Health Affiliated Investigators Participate in 90 Studies Featured at ASCO 2013 Studies have a wide-range of focus including ...
Varian Medical Systems is an American radiation oncology treatments and software maker based in Palo Alto, California.Their medical devices include linear accelerators (LINACs) and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy.
The American Society of Clinical Oncology (ASCO) is a professional organization representing physicians of all oncology sub-specialties who care for people with cancer. Founded in 1964 by Fred Ansfield , Harry Bisel , Herman Freckman, Arnoldus Goudsmit, Robert Talley, William Wilson, and Jane C. Wright , it has nearly 45,000 members worldwide.
In 2019, JTCC received approval from the National Cancer Institute (NCI) as a member of the NCI-approved Georgetown Lombardi Comprehensive Cancer Center. [6] The partnership focuses on advancing research and treatment in breast cancer, cancer prevention and control, experimental therapeutics and molecular oncology.
A physician by training, Long practices radiation oncology at a hospital in Kentucky. Long is the author of Evidence of the Afterlife: The Science of Near-Death Experiences, which appeared on The New York Times Best Seller list. In 1998, he founded the Near Death Experience Research Foundation, which is concerned with documenting and ...
McKesson would acquire about a 70% stake in the unit, which would be part of its U.S. pharmaceutical segment. Upon the close of the transaction, Florida Cancer Specialists — which operates in ...